Relmada Therapeutics
1 Follower
About
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain.
- Website
- Headquarters
- Industry
- Social
Org chart
View all (19)
Sergio Traversa
CEO
Charles S. Ence
Chief Accounting and Compliance Officer
Maged Shenouda
Chief Financial Officer
Molly Harper
EVP, Operations
Marc de Somer
SVP, Clinical Development
Marco Pappagallo
Acting Chief Medical Officer
Judy Caron
Vice President of Drug Development
Charles E. Inturrisi
Advisor
Charles J. Casamento
Chairman of the Board
Eric T. Schmidt
Director
John Glasspool
Director
Maurizio Fava
Advisor
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.